Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhanced Akt3 kinase activity reduces atherosclerosis in hyperlipidemic mice in a gender-dependent manner

Journal of Biological Chemistry(2023)10.1016/j.jbc.2023.105425Source: DataRank Database

Enhanced Akt3 kinase activity reduces atherosclerosis in hyperlipidemic mice in a gender-dependent manner is a research paper published in Journal of Biological Chemistry (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.18)OA: goldTopics (56)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Jessica Altemus,Liang Ding ORCID,О. Е. Черепанова ORCID,Tatiana V. Byzova ORCID,Eugene A. Podrez ORCID

Live enrichment

PubMed:37926285 PMC:PMC10716582 OpenAlex:https://openalex.org/W4388347158

National Institutes of Health

Grant: RO1 142772

National Institutes of Health

Grant: RO1 HL 126738

National Institutes of Health

Grant: RO1 HL 150193

NHLBI NIH HHS

Grant: R01 HL071625

NHLBI NIH HHS

Grant: R01 HL126738

NHLBI NIH HHS

Grant: R01 HL142772

NHLBI NIH HHS

Grant: R01 HL150193

National Institutes of Health

Grant: 5R01HL126738-03

Mechanism of atheroprotective function of Akt3 kinase

FWCI

0.18

Citation Percentile

0.5%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.jbc.org/article/S0021925823024535/pdf

publisherhttp://www.jbc.org/article/S0021925823024535/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0021925823024535?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925823024535?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jbc.2023.105425

Fields of Study

PI3K/AKT/mTOR signaling in cancerKruppel-like factors researchNuclear Receptors and Signaling0301 basic medicine03 medical and health sciencesAnimalsMaleMiceApolipoproteins EAtherosclerosisHyperlipidemiasInterleukin-6Mice, Inbred C57BLMice, KnockoutProto-Oncogene Proteins c-aktTumor Necrosis Factor-alpha

MeSH Terms

AnimalsApolipoproteins EHyperlipidemiasMaleMice, Inbred C57BLTumor Necrosis Factor-alphaInterleukin-6Mice, KnockoutAtherosclerosisProto-Oncogene Proteins c-aktMice

Keywords

AKT3Apolipoprotein EApoptosisMolecular biologyBiologyEndocrinologyInternal medicineCancer researchProtein kinase BMedicineBiochemistryAKT1AtherosclerosisMigrationCytokinesMacrophageInflammationGenderMaleMice, KnockoutInterleukin-6Tumor Necrosis Factor-alphaHyperlipidemiasMice, Inbred C57BLMiceApolipoproteins EAnimalsProto-Oncogene Proteins c-aktResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being